LPCAT1 and prostate carcinoma: Upregulation of LPCAT1 has been observed in clear renal cell carcinoma, oral squamous cell carcinoma, hepatoma, esophageal cancers, gastric cancers, breast cancers, colorectal cancers, and prostate cancers [136].